The guidance on Requests for Feedback
on Medical Device Submissions (Pre-Submissions Program) establishes
a structured process for submission and management of
Pre-Submissions and supports the procedures that CDRH and CBER
intend to follow when manufacturers, their representatives, or
application sponsors submit a request for feedback on a medical
device submission, including when the preferred method of feedback
is a meeting with review staff. The guidance also provides
recommendations regarding how to prepare for meetings with FDA
staff. These voluntary information collection requirements support
a structured process with clear recommendations for sponsors who
submit a pre-submission feedback request and for FDA staff and
managers involved in their review, as well as expected timeframes
for scheduling meetings.
Our estimated burden for the
information collection reflects an overall increase of 143,713
hours. We attribute this adjustment to an increase in the number of
submissions we received based on FY18 data.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.